Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn A A Oldham

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Biological Therapy|June 7, 2017
Practical considerations for chimeric antigen receptor design and deliveryRobyn A A Oldham, Jeffrey A Medin
International Journal of Molecular Sciences|September 13, 2016
Development of Novel Immunotherapies for Multiple MyelomaEnsaf M Al-Hujaily, Robyn A A Oldham, Parameswaran Hari, et al.
Scientific Reports|April 16, 2021
Sarcoma IL-12 overexpression facilitates NK cell immunomodulationMary Jo Rademacher, Anahi Cruz, Mary Faber, et al.
Inorganic Chemistry|September 14, 2012
Trifunctional metal ion-catalyzed solvolysis: Cu(II)-promoted methanolysis of N,N-bis(2-picolyl) benzamides involves unusual Lewis acid activation of substrate, delivery of coordinated nucleophile, powerful assistance of the leaving group departureMark A R Raycroft, Christopher I Maxwell, Robyn A A Oldham, et al.
Journal for Immunotherapy of Cancer|August 11, 2020
Discovery and validation of surface <i>N</i>-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targetsRobyn A A Oldham, Mary L Faber, Theodore R Keppel, et al.
Frontiers in Immunology|August 30, 2023
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activityMary L Faber, Robyn A A Oldham, Archana Thakur, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|June 7, 2017
Practical considerations for chimeric antigen receptor design and deliveryRobyn A A Oldham, Jeffrey A Medin
International Journal of Molecular Sciences|September 13, 2016
Development of Novel Immunotherapies for Multiple MyelomaEnsaf M Al-Hujaily, Robyn A A Oldham, Parameswaran Hari, et al.
Scientific Reports|April 16, 2021
Sarcoma IL-12 overexpression facilitates NK cell immunomodulationMary Jo Rademacher, Anahi Cruz, Mary Faber, et al.
Inorganic Chemistry|September 14, 2012
Trifunctional metal ion-catalyzed solvolysis: Cu(II)-promoted methanolysis of N,N-bis(2-picolyl) benzamides involves unusual Lewis acid activation of substrate, delivery of coordinated nucleophile, powerful assistance of the leaving group departureMark A R Raycroft, Christopher I Maxwell, Robyn A A Oldham, et al.
Journal for Immunotherapy of Cancer|August 11, 2020
Discovery and validation of surface <i>N</i>-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targetsRobyn A A Oldham, Mary L Faber, Theodore R Keppel, et al.
Frontiers in Immunology|August 30, 2023
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activityMary L Faber, Robyn A A Oldham, Archana Thakur, et al.
Pageof 1